Balaji Sitharaman
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.6MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2017 | NIH | SBIR Phase I CRISPR Cas Systems Delivered by Targeted Nanoparticles to Eradicate Herpesvirus Pathogens | $306K | Theragnostic Technologies Inc. |
| Mar 16, 2017 | NIH | SBIR Phase I CRISPR-Cas9 Systems Delivered by Targeted Nanoparticles to Eradicate Herpesvirus Pathogens | $306K | Theragnostic Technologies Inc. |
| May 12, 2016 | NIH | SBIR Phase II Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure | $718K | Theragnostic Technologies Inc. |
| Jun 15, 2015 | NIH | SBIR Phase II Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure | $771K | Theragnostic Technologies Inc. |
| Jun 15, 2015 | NIH | SBIR Phase II Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure | $1.5M | Theragnostic Technologies Inc. |
Peer ranks
Federal funding#501
Awards as PI#470
Patents#505
Companies
- Theragnostic Technologies Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.